273
Participants
Start Date
July 24, 2019
Primary Completion Date
April 29, 2021
Study Completion Date
April 29, 2021
Olorinab
Olorinab Dose 1 capsule or tablet by mouth, 3 times per day up to 12 weeks
Olorinab
Olorinab Dose 2 capsule or tablet by mouth, 3 times per day up to 12 weeks
Olorinab
Olorinab Dose 3 capsule or tablet by mouth, 3 times per day up to 12 weeks
Placebo
Olorinab matching placebo capsule or tablet by mouth, 3 times per day up to 12 weeks
Olorinab
Olorinab Dose 2 capsule or tablet by mouth, 3 times per day up to 52 weeks
Olorinab
Olorinab Dose 3 capsule or tablet by mouth, 3 times per day up to 52 weeks
Long Island Gastrointestinal Research Group LLP, Great Neck
Susquehanna Research Group, LLC, Harrisburg
Care Access Research, Pottsville, Pottsville
Frederick Gastroenterology Associates, Frederick
New River Valley Research Institute, Christiansburg
Exemplar Research Inc, Morgantown
Peters Medical Research, LLC, High Point
Medication Management, LLC, Greensboro
M3 Wake Research, Raleigh
Clinical Research of Gastonia, Gastonia
Clinical Trials of South Carolina, Charleston
Coastal Carolina Research Center, Mt. Pleasant
Clinical Research of Rock Hill, Rock Hill
Clinical Research Atlanta, Stockbridge
Agile Clinical Research Trials LLC, Atlanta
WR-Mount Vernon Clinical Research, LLC, Sandy Springs
Atlanta Center for Medical Research, Atlanta
Gastroenterology Associates of Gainesville Georgia, Gainesville
Columbus Regional Research Institute, Columbus
Qps Mra, Llc, South Miami
Precision Clinical Research, LLC., Sunrise
Clinical Research of Brandon, LLC, Brandon
Presicion Research Center Inc, Tampa
Accel Research Sites - Birmingham Clinical Research Unit, Birmingham
Clinical Research Associates, LLC, Huntsville
Chattanooga Research & Medicine, PLLC, Chattanooga
WR-ClinSearch, LLC, Chattanooga
Clinical Neuroscience Solutions, Inc., Memphis
Great Lakes Gastroenterology Research, LLC, Mentor
Great Lakes Medical Research, Beachwood
Rapid Medical Research, Inc., Cleveland
Family Practice Center of Wadsworth, Inc. dba New Venture Medical Research, Wadsworth
MediSphere Medical Research Center, LLC, Evansville
Flint Clinical Research, PLLC, Flint
University of Iowa Hospitals and Clinics, Iowa City
Meridian Clinical Research, LLC, Dakota Dunes
Lemah Creek Clinical Research, Oakbrook Terrace
Claude Mandel Medical Center, Chicago
Center for Pharmaceutical Research, LLC an AMR company, Kansas City
WestGlenGI, Shawnee Mission
CroNOLA, LLC, Houma
Clinical Trials of SWLA, LLC, Lake Charles
Louisiana Research Center, LLC, Shreveport
Central Sooner Research, Norman
Digestive Disease Specialists, Inc., Oklahoma City
Lynn Health Science Institute, Oklahoma City
Lynn Institute of Tulsa, Tulsa
Research Studies at Fine Digestive Health, Irving
Biopharma Informatic, LLC, Houston
Clinical Trial Network, Houston
Lynn Institute of Denver, Aurora
Advanced Clinical Research, Attn to: Owen Havey, Meridian
ACR Gut Whisperer, West Jordan
East Valley Gastroenterology and Hepatology Associates, Chandler
Gilbert Center for Family Medicine, Gilbert
Alliance Research Institute, Canoga Park
GW Research, Inc., Chula Vista
TriWest Research Associates, LLC, El Cajon
Diagnamics Inc., Encinitas
San Diego Gastroenterology Medical Associates (CTNx), San Diego
Precision Research Institute, San Diego
Medical Associates Research Group, San Diego
Prime Care Clinical Research, Laguna Hills
Advanced Rx Clinical Research Group, Inc., Westminster
Kindred Medical Institute for Clinical Trials, LLC, Corona
Om Research, Attn: Heather Blunt, Lancaster
Oregon Center for Clinical Investigations, Inc. (OCCI, Inc.), Salem
MultiCare Institute for Research & Innovation, Tacoma
Hassman Research Institute, Berlin
Lead Sponsor
Arena Pharmaceuticals
INDUSTRY